Скачать или смотреть Rapid COVID-19 Testing Based on New Biolabeling Technology is in Development

Before the pandemic, Srikanth Singamaneni was working towards a solution for medical testing at Washington University in St. Louis. His team had already created a technology platform for the detection of proteins present with diseases. It’s a rapid, highly sensitive and accurate biosensor proven to detect lower quantities of proteins related to certain diseases. But with COVID-19, the National Science Foundation awarded his lab over $100,000 to advance the technology for SARS-Co-V-2. Singamaneni’s team is developing a rapid SARS-Co-V-2 antibody test, as well as an antigen test for active COVID-19 infections. The biosensor is based on an ultrabright fluorescent nanoprobe, called plasmonic-fluor, composed of gold nanoparticles as beacons.